These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 325711)

  • 1. Prolongation of murine skin allografts by prostaglandin E1.
    Anderson CB; Jaffee BM; Graff RJ
    Transplantation; 1977 May; 23(5):444-7. PubMed ID: 325711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of mouse carcinoma in vivo with a prostaglandin E2 analogue and indomethacin.
    Bennett A; Carroll MA; Melhuish PB; Stamford IF
    Br J Cancer; 1985 Aug; 52(2):245-9. PubMed ID: 4027166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effect of prostaglandin E2 on the immune response in mice, with special reference to anti-sperm immunity.
    Bratanov K; Tornyov A; Somlev B; Velev B
    Int J Fertil; 1986; 31(4):305-10. PubMed ID: 2878901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrocortisone and inhibitors of prostaglandin synthesis. Potentiation of allograft survival in mice.
    Belldegrün A; Cohen IR; Frenkel A; Servadio C; Zor U
    Transplantation; 1981 Jun; 31(6):407-8. PubMed ID: 7020178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E prolongation of murine skin allografts.
    Anderson CB; Graff RJ; Jaffe BM
    Surg Forum; 1976; 27(62):330-2. PubMed ID: 798332
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of endogenous and exogenous prostaglandin E on Friend erythroleukaemia cell growth and differentiation.
    Santoro MG; Benedetto A; Jaffe BM
    Br J Cancer; 1979 Mar; 39(3):259-67. PubMed ID: 223618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intragraft delivery of 16, 16-dimethyl PGE2 induces donor-specific tolerance in rat cardiac allograft recipients.
    Kamei T; Callery MP; Flye MW
    Transplantation; 1991 Jan; 51(1):242-6. PubMed ID: 1987694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What regulates placental steroidogenesis in 90-day pregnant ewes?
    Weems YS; Kim L; Tsuda V; Yin C; Weems CW
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
    Gerlag PG; Koene RA; Hagemann JF; Wijdeveld PG
    Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of T cell homing by alloantibody.
    Chang AE; Sugarbaker PH
    Transplantation; 1980 Feb; 29(2):127-32. PubMed ID: 6986686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine and skin allografts for the treatment of thermal injury. I. Extensive graft survival with low-level long-term administration and prolongation in a rat burn model.
    Hewitt CW; Black KS; Aguinaldo AM; Achauer BM; Howard EB
    Transplantation; 1988 Jan; 45(1):8-12. PubMed ID: 3276067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
    Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
    Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged skin allograft survival through enhancement effects on donor tissue.
    Deutsch HL; Edington HD; McCullough CM; Sugarbaker PH
    Transplantation; 1986 Aug; 42(2):200-4. PubMed ID: 3526658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous prostaglandins, adenosine 3':5'-monophosphate and sodium transport across isolated frog skin.
    Hall WJ; O'Donoghue JP; O'Regan MG; Penny WJ
    J Physiol; 1976 Jul; 258(3):731-53. PubMed ID: 185363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM; Capel PJ; Koene RA
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy.
    Brenner DE; Harvey HA; Lipton A; Demers L
    Cancer; 1982 Feb; 49(3):556-61. PubMed ID: 7059914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.